<DOC>
	<DOCNO>NCT00001027</DOCNO>
	<brief_summary>Primary : To compare pharmacokinetics biweekly monthly dose regimen intravenous pentamidine HIV-infected infant child require PCP prophylaxis intolerant oral trimethoprim - sulfamethoxazole . To determine safety tolerance regimens patient population . Secondary : To obtain information rate PCP breakthrough infant child receive parenteral pentamidine prophylaxis . Prophylaxis Pneumocystis carinii pneumonia recommend HIV-infected child consider high risk . In child young 5 year age intolerance trimethoprim - sulfamethoxazole , parenteral pentamidine may successful alternative .</brief_summary>
	<brief_title>A Study Pentamidine Prevention Pneumocystis Carinii Pneumonia ( PCP ) HIV-Infected Children Who Can Take Trimethoprim-Sulfamethoxazole</brief_title>
	<detailed_description>Prophylaxis Pneumocystis carinii pneumonia recommend HIV-infected child consider high risk . In child young 5 year age intolerance trimethoprim - sulfamethoxazole , parenteral pentamidine may successful alternative . Thirty-two child randomize one two treatment arm . Patients receive pentamidine either biweekly monthly treatment schedule . Treatment continue last child enrol receive least 6 month pentamidine . Patients stratify accord age &lt; 24 month age &gt; = 24 month . Steady-state pharmacokinetics examine subsample 20 patient .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Steroids intravenous immune globulin ( IVIG ) . Patients must : Documented HIV infection . Need PCP prophylaxis . Known intolerance trimethoprim sulfamethoxazole ( TMPSMX ) . One follow require condition : Known intolerance allergy dapsone ; G6PD deficiency ; history serious lifethreatening reaction TMPSMX ; exclusion protocol ACTG 179 ; election parent enroll child ACTG 179 ; receive medical care sit participate ACTG 179 . NOTE : Coenrollment ACTG pediatric study permit . Consent parent guardian require . Prior Medication : Allowed : Prior pentamidine . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Active PCP . Pancreatitis define amylase elevation associate elevated lipase &gt; 2 x upper limit normal . Prior Medication : Excluded : TMPSMX dapsone within 7 day prior study entry ( toxicity TMPSMX dapsone must clearly resolve ) .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>